Morgan Stanley's basic assumption is that sunevision's MSR business will grow by 2% annually from 2024 to 2026.
According to the Zhongtong Finance APP, Morgan Stanley released a research report stating that the target price of sunevision (01686) was slightly raised by 9.5%, from 4.2 Hong Kong dollars to 4.6 Hong Kong dollars, with unchanged profit forecast and a "shareholding" rating.
The bank stated that the basic assumption is that sunevision's MSR business will grow by 2% annually from 2024 to 2026, and the blended utilization rates for 2024 to 2026 are 64.1%, 70.3%, and 44.3%, respectively. General and administrative expenses percentages are 3.8%, 3.5%, and 3.4%, respectively.
